Eric Easom, Chief Executive Officer at AN2 Therapeutics, Inc. (ANTX), bought 50,000 shares at $1.00 ($50K) on 2024-11-18, disclosed to the SEC on 2024-11-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| ANTX | BUY | 2023-05-15 | $54K | — | Filing → |
| ANTX | SELL | 2022-11-14 | $136K | — | Filing → |
| ANTX | SELL | 2022-11-09 | $426K | — | Filing → |